# Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

> **NCT00571714** · NA · WITHDRAWN · sponsor: **University of Nebraska**

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Peginterferon alpha-2a and ribavirin
- **DRUG:** Peginterferon alpha-2a , ribavirin and betaine

## Key facts

- **NCT ID:** NCT00571714
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-04-01
- **Primary completion:** 2010-03-04
- **Final completion:** 2010-03-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571714, "Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00571714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*